March 19, 2002
AmeriPath to Present at Banc of America Genomics and Diagnostics
Conference
Riviera Beach, FL, March 19, 2002 – AmeriPath, Inc. (Nasdaq:PATH),
one of the nation’s leading providers of anatomic pathology
services, today announced it will participate in the Banc of America
Securities Genomics and Diagnostics Conference 2002 to be held
at the The Pierre Hotel in New York City, New York. The AmeriPath
presentation will be made by the Company’s Executive Vice
President of Genomic Strategies and Chief Medical Officer, Dennis
M. Smith, Jr., M.D., on Wednesday, March 20, 2002, at 3:00 p.m.
Eastern Time.
The public is invited to listen to a webcast of the live presentation
via the Internet and an archived replay for two weeks at the following
web address: http://www.veracast.com/webcasts/BAS/genomics-2002/id82109323.cfm.
The webcast and replay will also be available on the AmeriPath
website, http://www.ameripath.com/.
AmeriPath is a leading national provider of cancer diagnostics,
genomics, and related information services. During 2001, AmeriPath
diagnosed approximately 4.0 million tissue biopsies, and interpreted
approximately 2.1 million Pap smears. The company’s extensive
diagnostics infrastructure includes over 400 pathologists and doctorate-level
scientists providing services in over 40 independent pathology
laboratories, more than 200 hospitals, the Center for Advanced
Diagnostics (CAD) and Dermpath Diagnostics, a division of AmeriPath.
CAD provides specialized diagnostic testing and information services
including Fluorescence In-Situ Hybridization (FISH), Flow Cytometry,
DNA Analysis, Polymerase Chain Reaction (PCR), Molecular Genetics,
Cytogenetics and HPV Typing. AmeriPath has over 60 board-certified
dermatopathologists supporting Dermpath Diagnostics, one of the
country’s leading providers of dermatopathology services
in the growing skin diagnostic market. Additionally, AmeriPath
provides clinical trial and research development support to firms
involved in developing new cancer and genomic diagnostics and therapeutics.
|
